13 Einträge gefunden

1. EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion

   1. Ariës, I M
   2. Jerchel, I S
   3. van den Dungen, R E S R
   4. van den Berk, L C J
   5. Boer, J M
   6. Horstmann, M A
   7. Escherich, G

   2014 - Forschungsinformationssystem des UKE
2. Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

   1. van der Veer, A
   2. van der Velden, V H J
   3. Willemse, M E
   4. Hoogeveen, P G
   5. Petricoin, E F
   6. Beverloo, H B
   7. Escherich, G

   2014 - Forschungsinformationssystem des UKE
3. Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia - an individual patient data meta-analysis involving 5,659 children

   1. Eden, TO
   2. Pieters, R
   3. Yetgin, S
   4. Olcay, L
   5. Dibar, E
   6. Conter, V
   7. Masera, G

   2010 - Forschungsinformationssystem des UKE
4. Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.

   1. Van Vlierberghe, P
   2. Homminga, I
   3. Zuurbier, L
   4. Gladdines-Buijs, J
   5. van Wering, E R
   6. Horstmann, Martin
   7. Beverloo, H B

   2008 - Forschungsinformationssystem des UKE
5. Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.

   1. Stams, [Unbekannt]
   2. Beverloo, [Unbekannt]
   3. Den, Boer
   4. Menezes, de
   5. Stigter, [Unbekannt]
   6. Drunen, van
   7. Ramakers-van-Woerden, [Unbekannt]

   2006 - Forschungsinformationssystem des UKE
6. Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia.

   1. Meier, M
   2. Den, Boer
   3. Meijerink, [Unbekannt]
   4. Broekhuis, [Unbekannt]
   5. Passier, [Unbekannt]
   6. Wering, van
   7. Janka-Schaub, Gritta

   2006 - Forschungsinformationssystem des UKE
7. Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia.

   1. Stam, [Unbekannt]
   2. Den, Boer
   3. Passier, [Unbekannt]
   4. Janka-Schaub, Gritta
   5. Sallan, [Unbekannt]
   6. Armstrong, [Unbekannt]
   7. Pieters, R

   2006 - Forschungsinformationssystem des UKE
8. Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.

   1. Meier, M
   2. den Boer, M L
   3. Hall, A G
   4. Irving, J A E
   5. Passier, M
   6. Minto, L
   7. van Wering, E R

   2005 - Forschungsinformationssystem des UKE
9. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.

   1. Stam, [Unbekannt]
   2. van Den, Heuvel-Eibrink
   3. Den, Boer
   4. Ebus, [Unbekannt]
   5. Janka-Schaub, Gritta
   6. Allen, [Unbekannt]
   7. Pieters, R

   2004 - Forschungsinformationssystem des UKE
10. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.

    1. Den, Boer
    2. Harms, [Unbekannt]
    3. Pieters, R
    4. Kazemier, [Unbekannt]
    5. Gobel, U
    6. Körholz, D
    7. Graubner, U

    2003 - Forschungsinformationssystem des UKE
11. In vitro glucocorticoid resistance in childhood leukemia correlates with receptor affinity determined at 37 degrees C, but not with affinity determined at room temperature.

    1. Haarman, [Unbekannt]
    2. Kaspers, [Unbekannt]
    3. Pieters, R
    4. Rottier, [Unbekannt]
    5. Den, Boer
    6. Janka-Schaub, Gritta
    7. Veerman, [Unbekannt]

    2002 - Forschungsinformationssystem des UKE
12. In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.

    1. Ramakers-van Woerden, N L
    2. Pieters, R
    3. Hoelzer, D
    4. Slater, R M
    5. den Boer, M L
    6. Loonen, A H
    7. Harbott, J

    2002 - Forschungsinformationssystem des UKE
13. In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia.

    1. Ramakers-van Woerden, N L
    2. Pieters, R
    3. Slater, R M
    4. Loonen, A H
    5. Beverloo, H B
    6. van Drunen, E
    7. Heyman, M

    2001 - Forschungsinformationssystem des UKE